Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tagrisso
Pharma
AstraZeneca bolsters Tagrisso's case amid J&J rivalry
The latest overall survival data help re-level the EGFR playing field for Tagrisso against J&J’s lung cancer combination of Rybrevant and Lazcluze.
Angus Liu
Sep 7, 2025 2:15am
AstraZeneca debuts TV ad for Tagrisso lung cancer treatment
Jul 23, 2025 1:37pm
AstraZeneca touts life-extension benefit for Tagrisso combo
Jul 21, 2025 2:59pm
J&J combo survival win signals new era in EGFR lung cancer
Mar 26, 2025 11:45am
AZ offers early look at Datroway-Tagrisso combo in lung cancer
Mar 19, 2025 7:05pm
J&J's Rybrevant-Lazcluze tops AZ's Tagrisso on overall survival
Jan 7, 2025 8:00am
